Web@article{Coolbrandt2024ARC, title={A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system.}, author={Annemarie Coolbrandt and H Tobback and Robert Govaerts and Lienke Vandezande and Magda Vinckx and A Laenen and Hans … WebPrevention of sensory oxaliplatin-induced peripheral neuropathy (OIPN) response (Phase II) [ Time Frame: Up to 1 month post-oxaliplatin treatment ] Will be measured using 6 individual Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 (QLQ-CIPN20) questions that quantify numbness, tingling, and pain in the fingers (or ...
Oxaliplatin-Associated Neuropathy OncoLink
Web30. máj 2024 · Oxaliplatin (OXA) is a commonly used platinum-based chemotherapy drug for colorectal cancer. OXA-induced peripheral neurotoxcity (OIPN) is a comprehensive … Web28. mar 2024 · As quality of life remains a key objective in these patients, protocol adaptations are frequent, notably regarding oxaliplatin to limit the cumulative peripheral neurotoxicity. 8 This leads to dose reductions or even early discontinuation, 9 which may reduce their impact on survival. 10 The use of a different platinum agent could have … tales of arise finding zephyr
DailyMed - OXALIPLATIN injection, solution
Web30. mar 2024 · Jose A, Holland AE, Oliveira CS, Selman JPR, Castro RAS, Athanazio RA, Rached SZ, Cukier A, Stelmach R, Corso SD. Does home-based pulmonary rehabilitation improve functional capacity, peripheral muscle strength and quality of life in patients with bronchiectasis compared to standard care? Braz J Phys Ther. 2024 Nov-Dec;21(6):473 … Web14. apr 2024 · Abstract. Introduction: Preclinical studies suggest cooperativity between blocking the human epidermal growth factor receptor 2 (HER2) and the vascular endothelial growth factor (VEGF) pathways in gastroesophageal adenocarcinomas (GEAs).Methods:Patients with previously untreated advanced HER2 positive GEAs were … WebMore than 30% of patients treated with neurotoxic chemotherapy agents develop peripheral neuropathy. 11 The risk is higher with cisplatin, paclitaxel, docetaxel, vincristine, oxaliplatin, and bortezomib. 12,13 The platinum-based 14 and other drugs 15–18 may lead to the “coasting” phenomenon ie, an increase in the severity of symptoms ... tales of arise fast travel disabled